Clinical Overview: Cannabis May Interact With Prescription Medications
An increase in cannabis use has led to growing concerns surrounding interactions between its components, THC and CBD, and prescription medications.
Stay updated with breaking news from Pharmd Candidate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An increase in cannabis use has led to growing concerns surrounding interactions between its components, THC and CBD, and prescription medications.
The estimated cost burden of schizophrenia is more than $150 billion, consisting of direct treatment cost and lost productivity.
Since the 2018 guideline’s publication, additional non-statin therapies such as bempedoic acid, evinacumab, and inclisiran, have been approved by the FDA for the management of hypercholesterolemia.
Pharmacists are crucial in supporting patients with attention-deficit hyperactivity disorder as shortages of Adderall continue.
/PRNewswire/ -- AMCP Foundation and CVS Health announced the recipients of AMCP Foundation's Best Poster Awards at AMCP 2023. This semiannual competition...